422 related articles for article (PubMed ID: 14695323)
21. Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549.
Sithanandam G; Fornwald LW; Fields J; Anderson LM
Oncogene; 2005 Mar; 24(11):1847-59. PubMed ID: 15688028
[TBL] [Abstract][Full Text] [Related]
22. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
[TBL] [Abstract][Full Text] [Related]
23. Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence.
Kammouni W; Ramakrishna G; Sithanandam G; Smith GT; Fornwald LW; Masuda A; Takahashi T; Anderson LM
Cell Growth Differ; 2002 Sep; 13(9):441-8. PubMed ID: 12354753
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
Lee HY
Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
[TBL] [Abstract][Full Text] [Related]
25. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway.
Wang L; Zhao Y; Xiong Y; Wang W; Fei Y; Tan C; Liang Z
Exp Cell Res; 2018 Jan; 362(2):424-435. PubMed ID: 29246726
[TBL] [Abstract][Full Text] [Related]
26. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
Rodenhuis S; Slebos RJ; Boot AJ; Evers SG; Mooi WJ; Wagenaar SS; van Bodegom PC; Bos JL
Cancer Res; 1988 Oct; 48(20):5738-41. PubMed ID: 3048648
[TBL] [Abstract][Full Text] [Related]
27. Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice.
Guerrero S; Figueras A; Casanova I; Farré L; Lloveras B; Capellà G; Trias M; Mangues R
FASEB J; 2002 Oct; 16(12):1642-4. PubMed ID: 12207005
[TBL] [Abstract][Full Text] [Related]
28. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
31. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
Kern JA; Slebos RJ; Top B; Rodenhuis S; Lager D; Robinson RA; Weiner D; Schwartz DA
J Clin Invest; 1994 Feb; 93(2):516-20. PubMed ID: 7906694
[TBL] [Abstract][Full Text] [Related]
32. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
Shimobaba S; Taga S; Akizuki R; Hichino A; Endo S; Matsunaga T; Watanabe R; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1170-8. PubMed ID: 26919807
[TBL] [Abstract][Full Text] [Related]
33. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation.
Ho CC; Huang PH; Huang HY; Chen YH; Yang PC; Hsu SM
Am J Pathol; 2002 Nov; 161(5):1647-56. PubMed ID: 12414512
[TBL] [Abstract][Full Text] [Related]
34.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
35. K-ras p21 expression and activity in lung and lung tumors.
Ramakrishna G; Sithanandam G; Cheng RY; Fornwald LW; Smith GT; Diwan BA; Anderson LM
Exp Lung Res; 2000 Dec; 26(8):659-71. PubMed ID: 11195463
[TBL] [Abstract][Full Text] [Related]
36. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.
Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P
Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
Guo L; Wang J; Yang P; Lu Q; Zhang T; Yang Y
IUBMB Life; 2015 Sep; 67(9):720-5. PubMed ID: 26314828
[TBL] [Abstract][Full Text] [Related]
38. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
[TBL] [Abstract][Full Text] [Related]
39. Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.
Zhong GX; Gong Y; Yu CJ; Wu SF; Ma QP; Wang Y; Ren J; Zhang XC; Yang WH; Zhu W
Tumour Biol; 2015 Jun; 36(6):4689-97. PubMed ID: 25619477
[TBL] [Abstract][Full Text] [Related]
40. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB
Carcinogenesis; 2007 Dec; 28(12):2589-96. PubMed ID: 17690114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
